Literature DB >> 29898963

Kidney Proximal Tubular TLR9 Exacerbates Ischemic Acute Kidney Injury.

Sang Jun Han1, Hongmei Li1, Mihwa Kim1, Mark J Shlomchik2, H Thomas Lee3.   

Abstract

The role for kidney TLR9 in ischemic acute kidney injury (AKI) remains unclear. In this study, we tested the hypothesis that renal proximal tubular TLR9 activation exacerbates ischemic AKI by promoting renal tubular epithelial apoptosis and inflammation. To test this hypothesis, we generated mice lacking TLR9 in renal proximal tubules (TLR9fl/fl PEPCK Cre mice). Contrasting previous studies in global TLR9 knockout mice, mice lacking renal proximal tubular TLR9 were protected against renal ischemia/reperfusion (IR) injury, with reduced renal tubular necrosis, inflammation (decreased proinflammatory cytokine synthesis and neutrophil infiltration), and apoptosis (decreased DNA fragmentation and caspase activation) when compared with wild-type (TLR9fl/fl) mice. Consistent with this, a selective TLR9 agonist oligonucleotide 1668 exacerbated renal IR injury in TLR9fl/fl mice but not in renal proximal tubular TLR9-null mice. Furthermore, in cultured human and mouse proximal tubule cells, TLR9-selective ligands induced NF-κB activation, proinflammatory cytokine mRNA synthesis, as well as caspase activation. We further confirm in the present study that global TLR9 deficiency had no impact on murine ischemic AKI. Taken together, our studies show that renal proximal tubular TLR9 activation exacerbates ischemic AKI by promoting renal tubular inflammation, apoptosis as well as necrosis, after IR via NF-κB and caspase activation. Our studies further suggest the complex nature of TLR9 activation, as renal tubular epithelial TLR9 promotes cell injury and death whereas TLR9 signaling in other cell types may promote cytoprotective effects.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29898963      PMCID: PMC6057798          DOI: 10.4049/jimmunol.1800211

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  Inflammation in acute kidney injury.

Authors:  Gilbert R Kinsey; Li Li; Mark D Okusa
Journal:  Nephron Exp Nephrol       Date:  2008-09-18

2.  Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.

Authors:  Hai Huang; Samer Tohme; Ahmed B Al-Khafaji; Sheng Tai; Patricia Loughran; Li Chen; Shu Wang; Jiyun Kim; Timothy Billiar; Yanming Wang; Allan Tsung
Journal:  Hepatology       Date:  2015-05-29       Impact factor: 17.425

3.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Authors:  Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

4.  Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes.

Authors:  I A Hilmi; D Damian; A Al-Khafaji; R Planinsic; C Boucek; T Sakai; C-C H Chang; J A Kellum
Journal:  Br J Anaesth       Date:  2015-02-10       Impact factor: 9.166

5.  A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury.

Authors:  Sang Won Park; Joo Yun Kim; Ahrom Ham; Kevin M Brown; Mihwa Kim; Vivette D D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-03

6.  CCR2 signaling contributes to ischemia-reperfusion injury in kidney.

Authors:  Kengo Furuichi; Takashi Wada; Yasunori Iwata; Kiyoki Kitagawa; Ken-Ichi Kobayashi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Hui Wang; Kouji Matsushima; Motohiro Takeya; William A Kuziel; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

7.  Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.

Authors:  Zubin M Bamboat; Vinod P Balachandran; Lee M Ocuin; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

8.  Toll-like receptor 9: a new target of ischemic preconditioning in the brain.

Authors:  Susan L Stevens; Thomas M P Ciesielski; Brenda J Marsh; Tao Yang; Delfina S Homen; Jo-Lynn Boule; Nikola S Lessov; Roger P Simon; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2008-01-09       Impact factor: 6.200

9.  TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons.

Authors:  Yasunori Shintani; Amar Kapoor; Masahiro Kaneko; Ryszard T Smolenski; Fulvio D'Acquisto; Steven R Coppen; Narumi Harada-Shoji; Hack Jae Lee; Christoph Thiemermann; Seiji Takashima; Kenta Yashiro; Ken Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

10.  TLR9 Mediates Remote Liver Injury following Severe Renal Ischemia Reperfusion.

Authors:  Pieter J Bakker; Angelique M Scantlebery; Loes M Butter; Nike Claessen; Gwendoline J D Teske; Tom van der Poll; Sandrine Florquin; Jaklien C Leemans
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

View more
  24 in total

1.  Peptidyl arginine deiminase-4 exacerbates ischemic AKI by finding NEMO.

Authors:  May M Rabadi; Sang Jun Han; Mihwa Kim; Vivette D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

2.  Norepinephrine released by intestinal Paneth cells exacerbates ischemic AKI.

Authors:  Sang Jun Han; Mihwa Kim; Vivette Denise D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-09

3.  Glomerular filtrate proteins in acute cardiorenal syndrome.

Authors:  Rumie Wakasaki; Katsuyuki Matsushita; Kirsti Golgotiu; Sharon Anderson; Mahaba B Eiwaz; Daniel J Orton; Sang Jun Han; H Thomas Lee; Richard D Smith; Karin D Rodland; Paul D Piehowski; Michael P Hutchens
Journal:  JCI Insight       Date:  2019-02-21

Review 4.  The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development.

Authors:  Tomohito Doke; Katalin Susztak
Journal:  Trends Cell Biol       Date:  2022-04-25       Impact factor: 21.167

Review 5.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

6.  B cell-intrinsic TLR9 expression is protective in murine lupus.

Authors:  Jeremy S Tilstra; Shinu John; Rachael A Gordon; Claire Leibler; Michael Kashgarian; Sheldon Bastacky; Kevin M Nickerson; Mark J Shlomchik
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 7.  Recent advances into the role of pattern recognition receptors in transplantation.

Authors:  Hrishikesh S Kulkarni; Davide Scozzi; Andrew E Gelman
Journal:  Cell Immunol       Date:  2020-03-07       Impact factor: 4.868

8.  Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury.

Authors:  Sang Jun Han; Ryan M Williams; Vivette D'Agati; Edgar A Jaimes; Daniel A Heller; H Thomas Lee
Journal:  Kidney Int       Date:  2020-02-22       Impact factor: 10.612

Review 9.  Mitochondrial DNA-Mediated Inflammation in Acute Kidney Injury and Chronic Kidney Disease.

Authors:  Lini Jin; Binfeng Yu; Ines Armando; Fei Han
Journal:  Oxid Med Cell Longev       Date:  2021-06-29       Impact factor: 6.543

Review 10.  Circulating Mitochondrial DNA Stimulates Innate Immune Signaling Pathways to Mediate Acute Kidney Injury.

Authors:  Jiaye Liu; Zhanjun Jia; Wei Gong
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.